Digestive Diseases and Sciences

, Volume 57, Issue 8, pp 2038–2044 | Cite as

Effect of Boswellia serrata on Antioxidant Status in an Experimental Model of Colitis Rats Induced by Acetic Acid

  • Renata Minuzzo Hartmann
  • Maria Isabel Morgan Martins
  • Juliana Tieppo
  • Henrique Sarubbi Fillmann
  • Norma Possa Marroni
Original Article


Aim of the Study

To evaluate the antioxidant effect of an extract of the plant Boswellia serrata in an experimental model of acute ulcerative colitis induced by administration of acetic acid (AA) in rats.

Materials and Methods

The extract of B. serrata (34.2 mg/kg/day) was administered orally by gavage for 2 days before and after induction of colitis with AA diluted to 4 % and in a volume of 4 ml.


The anal sphincter pressure in the groups treated with B. serrata showed a significant increase compared to the colitis group (P < 0.001). Histological analysis of treated animals showed less edema with preservation of mucosal crypts. Lipid peroxidation showed a significant decrease in the treated groups compared to the colitis group (P < 0.001). The superoxide dismutase (SOD) enzyme activity showed a significant reduction in the treated groups compared to the colitis group (P < 0.001), the glutathione peroxidase (GPx) significantly increased in the treated groups compared to colitis group (P < 0.05), and the same was the result for enzyme activity glutathione (GSH; P < 0.05).


The extract of B. serrata has active antioxidant substances that exert protective effects in acute experimental colitis.


Antioxidant Boswellia serrata Inflammation Oxidative stress Radical scavenger Ulcerative colitis 



One-way analysis of variance


Glutathione peroxidase




Inflammatory bowel disease


Inducible nitric oxide


Lipid peroxidation


Nitric oxide


Reactive oxygen species


Superoxide dismutase


Ulcerative colitis



Supported by grants from the Brazilian agencies Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Fundo de Incentivo à Pesquisa e Eventos (FIPE/ proj nº 110215) of the Hospital de Clínicas de Porto Alegre (HCPA), and Laboratório de Hepatologia e Gastroenterologia Experimental (HCPA/UFRGS) of the Universidade Federal do Rio Grande do Sul (UFRGS).

Conflict of interest



  1. 1.
    Cotran R, Kumar V, Robbins S. Pathologic Basis of Disease. 6a ed. Pennsylvania: Saunders; 1999:1524.Google Scholar
  2. 2.
    Hibi T, Ogata H. Novel pathophysiological concepts of inflammatory bowel disease. J Gastroenterol. 2006;41:10–16.PubMedCrossRefGoogle Scholar
  3. 3.
    Kelly CD. Inflammatory bowel disease, gut bacteria and probiotic therapy. J Med Microbiol. 2010;300:25–33.CrossRefGoogle Scholar
  4. 4.
    Pavlick KP, Laroux FS, Fuseler J, et al. Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease. Free Radic Biol Med. 2002;33:311–322.PubMedCrossRefGoogle Scholar
  5. 5.
    Grisham MB. Oxidants and free radicals in inflammatory bowel disease. Lancet. 1994;344:859–861.PubMedCrossRefGoogle Scholar
  6. 6.
    Tüzün A, Erdil A, Inal V, Aydin A, Bağci S, Yeşilova Z. Oxidative stress and antioxidant capacity in patients with inflammatory bowel disease. Clin Biochem. 2002;35:569–572.PubMedCrossRefGoogle Scholar
  7. 7.
    Pravda J. Radical induction theory of ulcerative colitis. World J Gastroenterol. 2005;11:2371–2384.PubMedGoogle Scholar
  8. 8.
    Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine. 4th ed. Oxford: Oxford University Press; 2007:851.Google Scholar
  9. 9.
    Yu BP. Cellular defenses against damage from reactive oxygen species. Physiol Rev. 1994;74:139–162.PubMedGoogle Scholar
  10. 10.
    Langmead L, Dawson C, Hawkins C, Banna N, Loo S, Rampton DS. Antioxidant effects of herbal therapies used by patients with inflammatory bowel disease: an in vitro study. Aliment Pharmacol Ther. 2002;16:197–205.PubMedCrossRefGoogle Scholar
  11. 11.
    Rahimi R, Shams-Ardekani MR, Abdollahi M. A review of the efficacy of traditional Iranian medicine for inflammatory bowel disease. World J Gastroenterol. 2010;16:4504–4514.PubMedCrossRefGoogle Scholar
  12. 12.
    Sharma S, Thawani V, Hingorani L, Shrivastava M, Bhate VR, Khiyani R. Pharmacokinetic study of 11-keto-β-Boswellic acid. Phytomedicine. 2004;11:1255–1260.CrossRefGoogle Scholar
  13. 13.
    Kimmatkar N, Thawani V, Hingorani L, Khiyani R. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee-a randomized double blind placebo controlled trial. Phytomedicine. 2003;10:3–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Huang MT, Badmaev V, Ding Y, Liu Y, Xie JG, Ho CT. Anti-tumor and anti-carcinogenic activities of triterpenoid, beta-boswellic acid. BioFactors. 2001;3:225–230.Google Scholar
  15. 15.
    Krüger P, Daneshfar R, Eckert GP, et al. Metabolism of boswellic acids in vitro and in vivo. Drug Metab Dispos. 2008;36:1135–1142.PubMedCrossRefGoogle Scholar
  16. 16.
    Yamada Y, Marshall S, Specian RD, Grisham MB. A comparative analysis of two models of colitis in rats. Gastroenterology. 1992;102:1524–1534.PubMedGoogle Scholar
  17. 17.
    Tannahill CL, Stevenot SA, Campbell-Thompson M, Nick HS, Valentine JF. Induction and immunolocalization of manganese superoxide dismutase in acute acetic acid-induced colitis in the rat. Gastroenterology. 1995;109:800–811.PubMedCrossRefGoogle Scholar
  18. 18.
    Krieglstein CF, Anthoni C, Rijcken EJ, et al. Acetyl-11-keto-β-boswellic acid, a constituent of a herbal medicine from Boswellia serrata resin, attenuates experimental ileitis. Int J Colorectal Dis. 2001;16:88–95.PubMedCrossRefGoogle Scholar
  19. 19.
    E.E.C. Council Directive 86/609/EEC of 24 November 1986 on the approximation of laws, regulations and administrative provisions of the Member States regarding the protection of animals used for experimental and other scientific purposes. Off J Eur Communities. 1986;L358:1.29.Google Scholar
  20. 20.
    Read NW, Sun WM. Anorectal manometry. In: Henry MM, Swash M, eds. Coloproctology and the Pelvic Floor. 2nd ed. London: Butterworth-Heinemann Ltd; 1992:119–145.Google Scholar
  21. 21.
    Llesuy SF, Milei J, Molina H, Boveris A, Milei S. Comparison of lipid peroxidation and myocardial damage induced by adriamycin and 4′-epiadriamycin in mice. Tumori. 1985;71:241–249.PubMedGoogle Scholar
  22. 22.
    Lowry OH, Rosebrough AL, Farr AL, Randall R. Protein measurement with the folin phenol reagent. World J Biol Chem. 1951;193:265–275.Google Scholar
  23. 23.
    Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol. 1978;52:302–309.PubMedCrossRefGoogle Scholar
  24. 24.
    Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. World J Biol Chem. 1972;247:3170–3175.Google Scholar
  25. 25.
    Flohé L, Beckmann R, Giertz H, Loschen G. Oxygen-centered free radicals as mediators of inflammation. In: Oxidative Stress. London: Academic; 1985:403–436.Google Scholar
  26. 26.
    Beutler E, Duran O, Kelly BM. Improved method for determination of blood glutathione. J Lab Clin Med. 1963;61:802–888.Google Scholar
  27. 27.
    Jurjus AR, Khoury NN, Reimund JM. Animal models of inflammatory bowel disease. J Pharmacol Toxicol Methods. 2004;50:81–92.PubMedCrossRefGoogle Scholar
  28. 28.
    Sailer ER, Subramanian LR, Rall B, Hoernlein RF, Ammon HP, Safayhi H. Acetyl-11-keto-β-boswellic acid (AKBA): structure requirements for binding and 5-lipoxygenase inhibitory activity. Br J Pharmacol. 1996;117:615–618.PubMedCrossRefGoogle Scholar
  29. 29.
    Anthoni C, Laukoetter MG, Rijcken E, et al. Mechanisms underlying the anti-inflammatory actions of boswellic acid derivatives in experimental colitis. Am J Physiol Gastrointest Liver Physiol. 2006;290:G1131–G1137.PubMedCrossRefGoogle Scholar
  30. 30.
    Fillmann H, Kretzmann NA, San-Miguel B, et al. Glutamine inhibits over-expression of pro-inflammatory genes and down-regulates the nuclear factor kappaB pathway in an experimental model of colitis in the rat. Toxicology. 2007;236:217–226.PubMedCrossRefGoogle Scholar
  31. 31.
    Kretzmann NA, Fillmann H, Mauriz JL, et al. Effects of glutamine on proinflammatory gene expression and activation of nuclear factor kappa B and signal transducers and activators of transcription in TNBS-induced colitis. Inflamm Bowel Dis. 2008;14:1504–1513.PubMedCrossRefGoogle Scholar
  32. 32.
    Ishihara T, Tanaka K, Tasaka Y, et al. Therapeutic effect of lecithinized superoxide dismutase against colitis. J Pharmacol Exp Ther. 2009;328:152–164.PubMedCrossRefGoogle Scholar
  33. 33.
    Latella G, Sferra R, Vetuschi A, et al. Prevention of colonic fibrosis by Boswellia and Scutellaria extracts in rats with colitis induced by 2,4,5-trinitrobenzene sulphonic acid. Eur J Clin Invest. 2008;38:410–420.PubMedCrossRefGoogle Scholar
  34. 34.
    Silva MS, Sánchez-Fidalgo S, Talero E, et al. Anti-inflammatory intestinal activity of Abarema cochliacarpos (Gomes) Barneby & Grimes in TNBS colitis model. J Ethnopharmacol. 2010;128:467–475.PubMedCrossRefGoogle Scholar
  35. 35.
    Varshosaz J, Emami J, Fassihi A, et al. Effectiveness of budesonide-succinate-dextran conjugate as a novel prodrug of budesonide against acetic acid-induced colitis in rats. Int J Colorectal Dis. 2010;25:1159–1165.PubMedCrossRefGoogle Scholar
  36. 36.
    Closa D, Folch-Puy E. Oxygen free radicals and the systemic inflammatory response. IUBMB Life. 2004;56:185–191.PubMedCrossRefGoogle Scholar
  37. 37.
    Dröge W. Free radicals in the physiological control of cell function. Physiol Rev. 2002;82:47–95.PubMedGoogle Scholar
  38. 38.
    Lee IA, Hyun YJ, Kim DH. Berberine ameliorates TNBS-induced colitis by inhibiting lipid peroxidation, enterobacterial growth and NF-κB activation. Eur J Pharmacol. 2010;648:162–170.PubMedCrossRefGoogle Scholar
  39. 39.
    Martinez AR, Marin J. Role of vascular nitric oxide in physiological and pathological conditions. Pharmacol Ther. 1997;75:111–134.CrossRefGoogle Scholar
  40. 40.
    Fillmann HS, Kretzmann N, Llesuy S, Fillmann LS, Marroni NP. O Papel do Óxido Nítrico na Pressão Anal Esfincteriana de Ratos Submetidos à Colite Experimental. Rev Bras Coloproctol. 2006;26:437–442.Google Scholar
  41. 41.
    Fillmann HS, Llesuy S, Marroni CA, Fillmann LS, Marroni NP. Diabetes mellitus and anal sphincter pressures: an experimental model in rats. Dis Colon Rectum. 2007;50:517–522.PubMedCrossRefGoogle Scholar
  42. 42.
    Tieppo J, Kretzmann NAF, Seleme M, Fillmann HS, Berghmans B, Marroni NP. Anal pressure in experimental diabetes. Dis Colon Rectum. 2009;24:1395–1399.Google Scholar
  43. 43.
    Sathyasaikumar KV, Swapna I, Reddy PV, et al. Fulminant hepatic failure in rats induces oxidative stress differentially in cerebral cortex, cerebellum and pons medulla. Neurochem Res. 2007;32:517–524.PubMedCrossRefGoogle Scholar
  44. 44.
    Oktyabrsky ON, Smirnova GV. Redox regulation of cellular functions. Biochemistry (Mosc). 2007;72:132–145.CrossRefGoogle Scholar
  45. 45.
    John S, Kale M, Rathore N, Bhatnagar D. Protective effect of vitamin E in dimethoate and malathion induced oxidative stress in rat erythrocytes. J Nutr Biochem. 2001;12:500–504.PubMedCrossRefGoogle Scholar
  46. 46.
    Spolarics Z, Wu JX. Role of glutathione and catalase in H2O2 detoxification in LPS-activated hepatic endothelial and Kupffer cells. Am J Physiol Gastrointest Liver Physiol. 1997;273:G1304.Google Scholar
  47. 47.
    Sengül N, Isik S, Aslim B, Uçar G, Demirbag AE. The effect of exopolysaccharide-producing probiotic strains on gut oxidative damage in experimental colitis. Dig Dis Sci. 2011;56:707–714.PubMedCrossRefGoogle Scholar
  48. 48.
    Shan X, Aw TY, Jones DP. Glutathione-dependent protection against oxidative injury. Aliment Pharmacol Ther. 1990;47:61–71.Google Scholar
  49. 49.
    Tahan G, Gramignoli R, Marongiu F, Aktolga S, Cetinkaya A, Tahan V. Melatonin expresses powerful anti-inflammatory and antioxidant activities resulting in complete improvement of acetic-acid-induced colitis in rats. Dig Dis Sci. 2011;56:715–720.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Renata Minuzzo Hartmann
    • 1
  • Maria Isabel Morgan Martins
    • 3
  • Juliana Tieppo
    • 2
  • Henrique Sarubbi Fillmann
    • 2
  • Norma Possa Marroni
    • 1
    • 2
    • 3
  1. 1.Programa de Pós-Graduação em Medicina: Ciências MédicasUniversidade Federal do Rio Grande do SulPorto AlegreBrazil
  2. 2.Laboratório de Hepatologia e Gastroenterologia ExperimentalHospital de Clínicas de Porto AlegrePorto AlegreBrazil
  3. 3.Laboratório de Estresse Oxidativo e AntioxidantesUniversidade Luterana do BrasilCanoasBrazil

Personalised recommendations